[ABCL] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
30-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ-
YoY-
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 9,362 11,228 4,657 3,202 3,451 2,479 2,479 141.92%
PBT -2,693 6,703 -2,093 -1,641 36 -303 -303 327.36%
Tax 0 0 0 82 0 0 0 -
NP -2,693 6,703 -2,093 -1,641 36 -303 -303 327.36%
Tax Rate - 0.00% - - 0.00% - - -
Total Cost 12,055 4,525 6,750 4,843 3,415 2,782 2,782 165.08%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -28.77 59.70 -44.94 -51.24 1.04 -12.22 -12.22 76.69%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.01 0.03 -0.01 -0.01 0.00 -0.00 -0.00 -
EPS Diluted -0.01 0.03 -0.01 -0.01 0.00 -0.00 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.